In the early stage, the majority of retinal diseases have no obvious symptoms and, during disease progression, current therapeutic options, such as surgery, laser photocoagulation, and anti-VEGF agents, all have significant limitations. Here, VEGFA is linked to Abnormal retinal morphology.